Company Overview of Roche Palo Alto, LLC
Roche Palo Alto, LLC engages in the discovery, development, and marketing of medicines for inflammatory or viral diseases. The company provides medicines for the treatment for a range of diseases, including severe asthma, chronic obstructive pulmonary disease, and rheumatoid arthritis. The company was formerly known as Syntex (U.S.A.) LLC and changed its name in 1994. The company was incorporated in 1960 and is based in Palo Alto, California. Roche Palo Alto, LLC operates as a subsidiary of Roche Holding AG.
3431 Hillview Avenue
Palo Alto, CA 94304
Founded in 1960
Key Executives for Roche Palo Alto, LLC
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Roche Palo Alto, LLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.